Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
- DOI
- 10.2215/cjn.14730920
- Published
- 2021-05-13
- Container
- Clin J Am Soc Nephrol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2215/cjn.14730920,
title = {Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.},
author = {Frishberg Y and Deschênes G and Groothoff JW and Hulton SA and Magen D and Harambat J and Van't Hoff WG and Lorch U and Milliner DS and Lieske JC and Haslett P and Garg PP and Vaishnaw AK and Talamudupula S and Lu J and Habtemariam BA and Erbe DV and McGregor TL and Cochat P and study collaborators.},
year = {2021},
journal = {Clin J Am Soc Nephrol},
doi = {10.2215/cjn.14730920},
url = {https://doi.org/10.2215/cjn.14730920}
}RIS
TY - JOUR TI - Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial. AU - Frishberg Y AU - Deschênes G AU - Groothoff JW AU - Hulton SA AU - Magen D AU - Harambat J AU - Van't Hoff WG AU - Lorch U AU - Milliner DS AU - Lieske JC AU - Haslett P AU - Garg PP AU - Vaishnaw AK AU - Talamudupula S AU - Lu J AU - Habtemariam BA AU - Erbe DV AU - McGregor TL AU - Cochat P AU - study collaborators. PY - 2021 JO - Clin J Am Soc Nephrol DO - 10.2215/cjn.14730920 UR - https://doi.org/10.2215/cjn.14730920 ER -
APA
Y, F., G, D., JW, G., SA, H., D, M., J, H., WG, V. H., U, L., DS, M., JC, L., P, H., PP, G., AK, V., S, T., J, L., BA, H., DV, E., TL, M., P, C., & collaborators., S. (2021). Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.. Clin J Am Soc Nephrol. https://doi.org/10.2215/cjn.14730920
Source records
- europe-pmc · retrieved 2026-09-26T03:41:42.859Z
- hal · retrieved 2026-09-26T03:41:42.900Z